The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2020
Filed:
Nov. 18, 2015
Applicant:
Molecular Templates, Inc., Austin, TX (US);
Inventors:
Brian A. Elenbaas, Melrose, MA (US);
Antonio Gualberto, Acton, MA (US);
Charles Praray Hart, Mountain View, CA (US);
Assignee:
MOLECULAR TEMPLATES, INC., Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6883 (2018.01); A61K 31/675 (2006.01); C07F 9/655 (2006.01); C07F 9/6553 (2006.01); C07F 9/6506 (2006.01); G01N 33/573 (2006.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); A61K 45/06 (2006.01); A61K 31/7068 (2006.01); G01N 33/50 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01); A61K 45/06 (2013.01); C07F 9/6506 (2013.01); C07F 9/65515 (2013.01); C07F 9/655345 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5011 (2013.01); G01N 33/573 (2013.01); G01N 33/574 (2013.01); A61K 9/0019 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/988 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7038 (2013.01);
Abstract
Enolase levels are predictive of the probability that a cancer patient will respond favorably to cancer therapy involving administration of hypoxia-activated achiral phosphoramide mustards.